Pfizer Inc. general counsel Amy Schulman picked up some new responsibilities this week in the wake of former CEO Jeffrey Kindler’s abrupt resignation on Dec. 5.
As part of an executive team shake-up by new CEO Ian Read on Tuesday, Schulman has been put in charge of the pharmaceutical giant’s nutrition business unit, which was acquired as part of Pfizer’s takeover of Wyeth Pharmaceuticals Inc. The nutrition business’ product portfolio includes a full line of infant formulas and other nutritional products for children.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
